Penumbra
Logotype for Penumbra Inc

Penumbra (PEN) investor relations material

Penumbra Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Penumbra Inc
Q3 2026 earnings summary29 Oct, 2026

Executive summary

  • Q3 revenue rose 15.6% YoY to $410.1M; operating income increased to $50.7M, while net income declined to $42.3M.

  • Nine-month revenue rose 15.4% YoY to $1.175B; operating income was $130.0M, while net income declined to $109.7M from $130.3M.

Financial highlights

  • Q3 gross profit was $280.3M versus $240.4M; operating expenses were $229.6M, including R&D of $25.4M and SG&A of $204.2M.

  • Q3 net income was $42.3M versus $45.9M; diluted EPS was $1.07 versus $1.17.

  • Nine-month gross profit was $798.7M versus $680.3M; diluted EPS was $2.77 versus $3.32.

  • Nine-month operating cash flow increased to $174.6M from $152.2M.

Outlook and guidance

  • No FY 2026 financial guidance or Q3 results conference call was provided given the pending Boston Scientific acquisition.

  • Liquidity is expected to cover requirements for at least 12 months; priorities include operations, manufacturing expansion, inventory, R&D and capital expenditures.

  • Continued investment planned for product launches, manufacturing and IT infrastructure, and international expansion; additional financing may be considered.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Penumbra earnings date

Logotype for Penumbra Inc
Q4 202619 Feb, 2027
Penumbra
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Penumbra earnings date

Logotype for Penumbra Inc
Q4 202619 Feb, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Penumbra Inc designs, develops, and markets medical devices for neurovascular and vascular conditions. Its products support treatments for stroke, peripheral embolization, and thrombectomy procedures, serving healthcare providers and hospitals worldwide. Penumbra operates within the healthcare and medical device sectors. The company is headquartered in Alameda, California, and its shares are listed on the NYSE.